Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Prolonged pregnancy

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44349   clinical trials with a EudraCT protocol, of which   7376   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    365 result(s) found for: Prolonged pregnancy. Displaying page 1 of 19.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2007-001313-42 Sponsor Protocol Number: OXN2001 (Inc. Amd 3) Start Date*: 2007-11-02
    Sponsor Name:Mundipharma Research GmbH & Co. KG
    Full Title: A randomised, double-blind, active-controlled, double-dummy, parallel group study to determine the safety and efficacy of oxycodone / naloxone prolonged release tablets in subjects with moderate to...
    Medical condition: subjects with moderate to severe, chronic cancer pain
    Disease: Version SOC Term Classification Code Term Level
    9.1 10058019 Cancer pain LLT
    9.1 10058019 Cancer pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) CZ (Completed) DE (Completed) HU (Completed) FR (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2012-004360-22 Sponsor Protocol Number: KF5503-66 Start Date*: 2014-10-02
    Sponsor Name:Grünenthal GmbH
    Full Title: An open label trial, enrolling subjects aged 6 years to less than 18 years suffering from pain requiring prolonged release opioid treatment, to evaluate the safety and efficacy of tapentadol PR ver...
    Medical condition: Pain requiring prolonged release opioid treatment.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000023314 10049475 Chronic pain LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) PT (Completed) ES (Completed) SK (Prematurely Ended) BE (Completed) IT (Completed) SI (Prematurely Ended) HU (Completed) BG (Completed) HR (Prematurely Ended) FR (Completed)
    Trial results: View results
    EudraCT Number: 2018-003063-64 Sponsor Protocol Number: 3005031 Start Date*: 2018-10-05
    Sponsor Name:Orion Corporation, Orion Pharma
    Full Title: Open clinical trial to evaluate safety, tolerability, and efficacy of Dexdor for sedation in paediatric patients in intensive care settings. Multi-centre trial in Russia for marketing registratio...
    Medical condition: male and female patients aged 12 to 17 years with spontaneous or artificial ventilation and clinical need for prolonged (>24h) light to moderate sedation.
    Disease:
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2020-001655-41 Sponsor Protocol Number: 35RC19_8877_DIPLOID Start Date*: 2020-09-15
    Sponsor Name:CHU de Rennes
    Full Title: P-glypoprotein inhibition effect on the pharmacokinetics of two tacrolimus formulations: prolonged and extended-release
    Medical condition: healthy volunteers
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-002670-36 Sponsor Protocol Number: OXN3503 Start Date*: 2009-01-30
    Sponsor Name:Mundipharma Research GmbH & Co. KG
    Full Title: A randomised, double-blind, double-dummy, parallel-group multicentre study to demonstrate non-inferiority in pain and locomotor function and improvement in symptoms of constipation in subjects with...
    Medical condition: Pain, locomotor function and improvement in constipation in osteoarthritis patients taking opioids
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031161 Osteoarthritis LLT
    9.1 10021175 Iatrogenic constipation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) HU (Completed) NL (Completed) ES (Completed) AT (Completed) FI (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2012-001772-11 Sponsor Protocol Number: OXN2505 Start Date*: 2014-01-23
    Sponsor Name:Mundipharma Research GmbH & Co. KG
    Full Title: An exploratory, double-blind, double-dummy, randomised, 2-period, crossover, Phase IIa study to assess the influence of oxycodone/naloxone prolonged-release tablets (OXN PR) and oxycodone prolonged...
    Medical condition: The intended indication is: Chronic severe non malignant pain, requiring opioids.
    Disease: Version SOC Term Classification Code Term Level
    16.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2006-005839-20 Sponsor Protocol Number: PPL02 Start Date*: 2007-02-05
    Sponsor Name:Dilafor AB
    Full Title: A randomised, double-blind, placebo-controlled, multicentre trial to access the safety and efficacy of pre-treatment with DF01 during late pregnancy in reducing prolonged labour.
    Medical condition: Pre-treatment during late pregnancy to reduce prolonged labour.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000993-32 Sponsor Protocol Number: S55300 Start Date*: 2013-05-07
    Sponsor Name:University Hospital Leuven
    Full Title: Does prolonged GnRH downregulation prior to ART improve the clinical pregnancy rate in postoperative endometriosis patients? A RCT
    Medical condition: endometriosis, subfertility
    Disease: Version SOC Term Classification Code Term Level
    15.1 100000004872 10042392 Subfertility (female) LLT
    15.1 100000004872 10014789 Endometriosis, site unspecified LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-005376-13 Sponsor Protocol Number: PMR-EC-1210 Start Date*: 2008-02-27
    Sponsor Name:Astellas Pharma Europe Ltd.
    Full Title: A MULTICENTER, FOUR ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY INVESTIGATING OPTIMIZED DOSING IN A PROGRAF®-/ ADVAGRAF®-BASED IMMUNOSUPPRESSIVE REGIMEN IN KIDNEY TRANSPLANT SUBJECTS. Protocol for P...
    Medical condition: Prophylaxis of rejection in kidney allograft recipients (via immunosuppression)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10023438 Kidney transplant LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) CZ (Completed) ES (Completed) HU (Completed) IE (Completed) GB (Completed) SE (Completed) NL (Completed) AT (Completed) GR (Completed) SK (Completed) PT (Completed) BE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-003510-15 Sponsor Protocol Number: OXN3006 (incl. Admin. Change 1) Start Date*: 2006-03-06
    Sponsor Name:Mundipharma Research GmbH & Co. KG
    Full Title: A randomised, double-blind, double-dummy, parallel-group multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of ...
    Medical condition: Moderate to severe chronic non-malignant pain that requires around-the-clock opioid therapy and also have constipation secondary to opioid treatment.
    Disease: Version SOC Term Classification Code Term Level
    7.1 10003988 pt
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) DE (Completed) GB (Completed) ES (Completed) CZ (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2005-002398-57 Sponsor Protocol Number: OXN3001 Start Date*: 2005-11-23
    Sponsor Name:Mundipharma Research GmbH & Co. KG
    Full Title: A randomized, double-blind, parallel-group, multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of >= 20 mg/day ...
    Medical condition: Moderate to severe non-malignant pain that requires around the clock opioid therapy and also have constipation secondary to opioid treatment.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10049475 Chronic pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) ES (Completed) DE (Completed) CZ (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-018118-21 Sponsor Protocol Number: OXN2503 Start Date*: Information not available in EudraCT
    Sponsor Name:Mundipharma Research GmbH & Co. KG
    Full Title: An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to place...
    Medical condition: Bladder Pain Syndrome (BPS), formerly addressed as IC/PBS (interstitial cystitis /Painful Bladder Syndrome)
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004857 10008927 Chronic interstitial cystitis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed) HU (Completed) CZ (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-016957-17 Sponsor Protocol Number: OXN4505 Start Date*: 2010-02-03
    Sponsor Name:Mundipharma Oy
    Full Title: A randomised, double-blind, parallel group multicenter study to demonstrate non-inferiority of the analgesic efficacy of oxycodone/naloxone 10/5 or 20/10 mg prolonged release tablets (OXN PR) BID c...
    Medical condition: postoperative pain after knee arthroplasty
    Disease: Version SOC Term Classification Code Term Level
    12.1 10036236 Postoperative pain relief LLT
    12.1 10054711 Postoperative pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2019-002032-84 Sponsor Protocol Number: ELYS-CS01 Start Date*: 2019-10-31
    Sponsor Name:Disphar International B.V
    Full Title: Evaluating the Use of a Progesterone Receptor Modulator for Cervical Ripening at Full Term Pregnancy – a Randomized, Double-blind , placebo controlled Study (LUCYNA)
    Medical condition: Full-term pregnancy women at week 40 + 5 of gestation with intact membranes, the first delivery, singleton physiological pregnancy
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004868 10036880 Prolonged pregnancy, with delivery LLT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-004635-30 Sponsor Protocol Number: UCL-ONCO-06-004 Start Date*: 2008-11-20
    Sponsor Name:CENTRE DU CANCER - CLINIQUES UNIVERSITAIRES SAINT-LUC
    Full Title: A randomized multicentric phase II study of prolonged adjuvant Temozolomide or "stop and go" in glioblastoma patients : the PATSGO study.
    Medical condition: It is an open-label, randomised multicentric phase II study of prolonged adjuvant Temozolomide versus "stop and go" in glioblastoma patients. This study will include a total of 70 patients. The st...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-002310-72 Sponsor Protocol Number: 0201/DEV Start Date*: 2016-03-29
    Sponsor Name:Develco Pharma Schweiz AG
    Full Title: Open-label, uncontrolled trial to evaluate pharmacokinetics of naloxone in children from 4 to less than 18 years of age with opioid-induced constipation
    Medical condition: Opioid induced constipation
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004856 10071128 Opioid induced constipation LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Temporarily Halted) HU (Prematurely Ended) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2008-002426-10 Sponsor Protocol Number: OXN4502 Start Date*: 2008-12-19
    Sponsor Name:Napp Pharmaceuticals Ltd
    Full Title: A double-blind, double-dummy, parallel group, randomised study to compare the efficacy and tolerability of oxycodone/naloxone prolonged release (OXN PR) and codeine/paracetamol in the treatment of...
    Medical condition: Moderate to severe chronic lowback pain or pain due to osteoarthritis of the hip and/or knee.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-000145-40 Sponsor Protocol Number: versión2.febrero2017 Start Date*: 2017-09-20
    Sponsor Name:montserrat zamora brito
    Full Title: Use of acupuncture for the reduction of hospital admissions in the induction of labor due to chronologically prolonged gestation. ACUPUNT STUDY
    Medical condition: This Clinical Trial will evaluate the efficacy and safety of acupuncture to promote labor in pregnant women who need an induction at birth and thus be able to give answers to all these women who a...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-001026-14 Sponsor Protocol Number: OXN3501 Start Date*: 2009-05-19
    Sponsor Name:Mundipharma Pharmaceuticals BV [...]
    1. Mundipharma Pharmaceuticals BV
    2. Mundipharma Comm VA
    Full Title: An open study with OXN to evaluate the patient preference for pain treatment with respect to quality of life after WHO step I or step II analgesics for patients with moderate to severe non-malignan...
    Medical condition: moderate to severe pain non-malignant pain
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033371 Pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2016-002118-40 Sponsor Protocol Number: PPL07 Start Date*: 2018-02-23
    Sponsor Name:Dilafor AB
    Full Title: Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Effect of continuous infusion of Tafoxiparin as an Adjunct Treatment to Oxytocin for up to 36 hours...
    Medical condition: Primary Slow Progress of Labor including prolonged latent phase and Primary Labor Arrest
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004868 10023539 Labor abnormal LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed) FI (Completed) DK (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jul 12 23:22:35 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA